Webinar: Robust and Cost-Effective mRNA Capping
Robust and Cost-Effective mRNA Capping:
Critical Quality Attributes and Manufacturing Strategies
December 8, 2025
11:00 AM ET
This webinar explores the latest advancements in RNA manufacturing, with a particular emphasis on the scalability of production processes. Special attention is given to capping strategies, highlighting their critical role in ensuring RNA stability and translational efficiency at industrial scales. Attendees will gain insights into current challenges and innovative solutions for optimizing capping processes in large-scale RNA synthesis.
Key learning objectives
- Dive into industrial mRNA capping insights
Adoption of new processes, technologies and materials: - Explore strategies to thoroughly assess the compatibility, performance, and effectiveness of new materials, such as Roche’s GMP Grade Vaccinia Capping Enzymes
- Scaling of mRNA synthesis processes from milliliter to liter in vitro transcription volume
Dr. Julian Mochayedi
Product Manager EMEA/LATAM, Roche CustomBiotech
Dr. Julian Mochayedi serves as the mRNA Portfolio Product & Marketing Manager for Roche CustomBiotech EMEA/LATAM, Roche's business-to-business division supplying high-quality, GMP Grade mRNA raw materials.
His deep expertise in the mRNA field is further enhanced by his translational research background from the DKFZ German Cancer Research Center. Julian's academic credentials include an M.Sc. in Bioprocess Development and a Ph.D. in Translational Immunology, from Heidelberg University.
Dr. Hagen Richter
Head of Nucleic Acid Research, Wacker Chemie AG
Hagen Richter is Head of Nucleic Acid Research at WACKER’s central R&D hub in Munich, leading a team focused on innovations in advanced therapy and mRNA vaccine process development. He holds a Ph.D. in Molecular Biology, an M.Sc. in Biotechnology, and completed postdoctoral research with Prof. Emmanuelle Charpentier. Hagen has co-authored 14 peer-reviewed papers, with academic work on small regulatory RNAs, DNA replication, and CRISPR RNA maturation.